Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT06730581
Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases
- Conditions
- Interventions
- First Posted Date
- 2024-11-11
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 118
- Registration Number
- NCT06683703
Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 84
- Registration Number
- NCT05700084
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2023-01-06
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 552
- Registration Number
- NCT05673629
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2023-01-06
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 612
- Registration Number
- NCT05673590
- Locations
- 🇨🇳
Shanghai Pulmonary Hospital, Shanghai, China
PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2021-09-22
- Last Posted Date
- 2023-01-10
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT05052437
- Locations
- 🇨🇳
Hunan Cancer Hospital, Changsha, Hunan, China
🇨🇳The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2021-06-03
- Last Posted Date
- 2023-11-08
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT04911907
- Locations
- 🇨🇳
Luhe Hospital, Capital Medical University, Beijing, China
🇨🇳Shanghai East Hospital of Tongji University, Shanghai, China
🇨🇳Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer
- First Posted Date
- 2019-04-08
- Last Posted Date
- 2023-01-10
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT03906565
- Locations
- 🇨🇳
Tianjin People's Hospital, Tianjin, China
🇨🇳Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
🇨🇳Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2023-01-10
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 26
- Registration Number
- NCT03693547
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳Peking Union Hospital, Beijing, Beijing, China
🇨🇳Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2019-04-09
- Lead Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 405
- Registration Number
- NCT02253459
- Locations
- 🇨🇳
Henan Cancer Hospital, Zhengzhou, Henan, China
🇨🇳Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
🇨🇳The General Hospital of the People's Liberation Army, Beijing, Beijing, China